The BMI, ALT, AST, γ-glutamyl transpeptidase (GGT), FINS, TG, HDL-C, LDL-C, UA, and HOMA-IR were significantly higher in the NAFLD group than those in the healthy control group (P < 0.05), but no significant differences were observed in FPG, TC, ApoA1, or ApoB between the two groups (P > 0.05). The gene discussed is APOB; the disease is metabolic dysfunction-associated steatotic liver disease.